Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H1846

MediGold

5,914 members

3

-1.0 vs 2026Below the 4 star line

Ask about H1846

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

3 · 2.0 pt to 4★

Medication Adherence for Hypertension (RAS antagonists)

4 · 2.0 pt to 5★

Medication Adherence for Cholesterol (Statins)

3 · 1.0 pt to 4★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan40.22
C17 Plan All-Cause Readmissions3x57%
C28 Members Choosing to Leave the Plan415%
C16 Improving Bladder Control240%
C19 Transitions of Care245%
C15 Reducing the Risk of Falling146%
C06 Monitoring Physical Activity248%
C13 Kidney Health Evaluation for Patients with Diabetes256%
C02 Colorectal Cancer Screening266%
C11 Diabetes Care – Eye Exam266%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.